Eye Drop

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Preeya K. Gupta, MD, presented a poster on the functional benefits of CSF-1 low-dose pilocarpine drops from Orasis Pharmaceuticals for the treatment of presbyopia.

Vyluma Inc. has announced that the FDA will review its new drug application for NVK002, a preservative-free, low-dose atropine eye drop for myopia in children aged 3 to 17 years.

An eye drop bottle cap monitor measured and improved adherence in patients with glaucoma, with 80% of users experiencing at least a 90% adherence rate, according to data published in Journal of Glaucoma.

In a 2020 position statement on microinvasive glaucoma surgery, the American Glaucoma Society said:

Yes, I am really going to write a column on over-the-counter drops for dry eye disease.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Marjan Farid, MD, presents the phase 3 data of CSF-1 0.4% pilocarpine solution from Orasis for the treatment of presbyopia.

In this video, Ronald L. Benner, OD, discusses exciting new research in dry eye.

SAN DIEGO — In this Healio Video Perspective from Eyecelerator@ASCRS, Ben Bergo gives an overview of the positive topline phase 3 results for the Brimochol PF eye drop for the treatment of presbyopia.

The CDC announced that 68 patients in 16 states have been identified as of March 21 with a drug-resistant strain of Pseudomonas aeruginosa believed to have originated in multidose bottles of artificial tears.

Lenz Therapeutics has raised $83.5 million in an oversubscribed Series B financing, according to a press release.